LOGEX is the European leader in advanced analytics for healthcare, serving providers, payors, and authorities. The company has the most comprehensive product portfolio in its field in Europe, and the broadest geographical reach. LOGEX has three main business units: Financial Analytics (e.g., cost, resource allocation, planning), Outcomes Analytics (e.g., healthcare quality outcome measurement and benchmarking), and Life Sciences (real world evidence data and analytics).
LOGEX
Overview
LOGEX at a glance
Key developments 2022
During 2022, the roll-out of the new Financial Analytics platform continued and the company expanded its life science business. Four add-on acquisitions have been completed since closing (Ensolution, Analysesentret, Assista, and COINS), strengthening the position for Financial Analytics across Europe. LOGEX also welcomed Thoma Bravo as a new investor in early 2023.
Sector
Healthcare analytics
Location
Europe
SDG aligment
Environmental
Carbon intensity: Tons CO₂e per EUR m revenue
Total tons CO₂ emitted
Change from '21-'22
2022
-0%
1 093
2021
1 517
2020
886
Monetized climate impact
EURm
The figure represents the monetized value the company has on the environment. See chapter 4 for methodology.
Social
Full time employees
Turnover16%
Unadjusted gender pay gap13%
Gender balance, % females
%
Board
%
Management
%
All employees
Monetized employment impact (EURm)
EURm
The figure represents the monetized value the company has as a quality employer. See chapter 4 for methodology.
Governance
Via Summa Compliance
%
✔ Code of conduct
✘ Supplier code of conduct
✘ Economic Sanctions
✘ Competition Law/Antitrust
✔ Data Protection/IT Security
✔ Anti-curruption
✔ Whistleblower
How LOGEX is advancing ESG
LOGEX is inherently a purpose-led and impact-focus technology company and delivers a meaningful and measurable positive impact in healthcare. By growing and expanding its reach, LOGEX can increase its real-world impact on patients while reducing cost for the healthcare system.
The company continues to advance its ESG agenda, and one key target is to capture more impact stories so to better build audiences and drive engagement with stakeholders.
What are the challenges LOGEX addresses?
0%
of OECD GDP is spent on healthcare
0m
shortage of health workers globally
How does LOGEX help?
Reality today
Healthcare systems face rising costs alongside ever-increasing needs to raise quality for patient care and outcomes.
LOGEX approach
LOGEX’s software solutions and analytical tools provide unprecedented insight into care delivery, cost, and patient outcomes, enabling more quality-centric, cost-conscious approaches to healthcare and pharma.
Aspirational future
Patients consistently receive care that is affordable, meets their needs, and passes the highest standards of quality.
What impact does LOGEX create?
Healthcare institutions using LOGEX tools
Change from '21-'22
Target 2026: 1 000
2022
+0%
720
2021
700
2020
550
Impact stories captured
Change from '21-'22
Target 2026: 150 bn
2022
+0%
20bn
2021
11bn
2020
0bn
Patients impacted (million)
Change from '21-'22
Target: 2026 250 m
2022
+0%
44m
2021
39m
2020
29m
Who is impacted?
Patients are impacted by the quality and affordability of care. Healthcare systems, including providers and payors, are impacted by cost and efficiency of care delivery.
What are the impact considerations?
Additionality
LOGEX’s growing suite of solutions is helping accelerate the transition to more cost-effective, patient-centric, and integrated care – without which healthcare systems will continue to deliver suboptimal outcomes.
Risks
LOGEX works to maintain the highest data privacy and security standards, including meeting internationally recognized certifications, in order to mitigate risks posed by handling healthcare and patient data. The company’s impact also depends on the pace of transformation towards value-based care. LOGEX is working to help drive an inflection point for more rapid change.